This article is more than 5 years old. Information may no longer be current.
Cardiology Today Editorial Board member recipient of Society of Nuclear Medicine award
Click Here to Manage Email Alerts
Daniel S. Berman, MD, chief of cardiac imaging and nuclear cardiology at the Cedars-Sinai S. Mark Taper Foundation Imaging Center, has been named this year’s recipient of the George Charles de Hevesy Nuclear Pioneer Award for his contributions to the nuclear medicine profession, according to a press release.
Berman was presented the award by the Society of Nuclear Medicine during the 2012 Annual Meeting in Miami Beach, Fla.
Daniel S. Berman
“I am honored and humbled to be the recipient of the de Hevesy award,” Berman stated in a release issued by Cedars-Sinai. “My contributions in the field of CV nuclear medicine are due to the unrivaled efforts of a world-class team of dedicated clinicians and scientists with whom I have had the great fortune to collaborate.”
Berman is recognized internationally as a leading clinical investigator in noninvasive cardiac imaging. His research focuses on new imaging methods and clinical applications of cardiac positron emission tomography, single-positron emission CT, CT and MRI. Berman played a key role in the development and advancement of multimodality cardiac imaging. He has written more than 600 journal articles and book chapters on these topics, according to a press release. He is also a member of the Imaging section of the Cardiology Today Editorial Board.
“Dr. Berman has contributed greatly to the field of nuclear cardiology and is responsible for creating the largest and most extensively studied patient database in cardiac imaging,” 2011-2012 Society of Nuclear Medicine president George Segall, MD, stated in the press release. “Having received more than $23 million in research grants throughout his career, he has been credited for a great number of innovations that have become standard in today’s clinical practice of nuclear cardiology. He has changed the way we practice nuclear medicine and molecular imaging for the better.”